SIGN UP

Resources

Sharing knowledge about promising practices and their sustainable implementation is vital to ending the opioid and drug overdose crisis. Our publications and webinars include the recommendations of experts and the perspectives of those on the frontlines.

All Resources

covid 19

Choose Type

All

COVID-19 Response

SAMHSA: FAQ on the provision of methadone and buprenorphine for the treatment of OUD in the COVID-19 Emergency

March 19, 2020
The Substance Abuse and Mental Health Services Administration (SAMHSA) has compiled an FAQ on prescribing MOUD during the COVID-19...

COVID-19 Response

Webinar: MOUD and the COVID-19 National Emergency Response

March 19, 2020
Join Dr. Hannah Snyder, Jodi Manz, MSW, and Daniel McClughen, Esq. as they review key steps, fast evolving regulatory changes, and...

COVID-19 Response

SAMHSA: COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance

March 19, 2020
The Substance Abuse and Mental Health Services Administration (SAMHSA) is providing guidance to ensure that SUD treatment services...

COVID-19 Response

FORE Opinion Letter: Prescribing Buprenorphine During a Public Health Emergency

April 1, 2020
Legal analysis of four hypothetical scenarios for prescribing buprenorphine for opioid use disorder in the United States during th...

COVID-19 Response

HHS/OCR: Enforcement Discretion for Telehealth Remote Communications During COVID-19

March 17, 2020
The Office for Civil Rights (OCR) will exercise enforcement discretion and will waive potential penalties for HIPAA violations aga...

COVID-19 Response

DEA: Expanded MOUD Telemedicine Guidance

March 17, 2020
The Drug Enforcement Administration (DEA) has provided further guidance on the expanded use of telemedicine for medications for op...